Kepos Capital LP United Therapeutics Corp Transaction History

Kepos Capital LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$79.39 - $115.35 $889,803 - $1.29 Million	-11,208 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$78.31 - $95.34 $161,083 - $196,114	2,057 Added 22.48%	11,208 $987,000
Q3 2019 Nov 13, 2019	SELL	$74.85 - $85.99 $1.46 Million - $1.67 Million	-19,450 Reduced 68.0%	9,151 $730,000
Q2 2019 Aug 13, 2019	SELL	$76.06 - $120.81 $2.11 Million - $3.35 Million	-27,725 Reduced 49.22%	28,601 $2.23 Million
Q1 2019 May 13, 2019	BUY	$107.15 - $126.84 $194,370 - $230,087	1,814 Added 3.33%	56,326 $6.61 Million
Q3 2018 Nov 13, 2018	BUY	$113.81 - $129.46 $3.51 Million - $3.99 Million	30,797 Added 129.86%	54,512 $6.97 Million
Q1 2018 May 14, 2018	BUY	$107.21 - $151.94 $446,100 - $632,222	4,161 Added 21.28%	23,715 $2.67 Million
Q4 2017 Feb 12, 2018	BUY	$118.58 - $151.28 $724,998 - $924,925	6,114 Added 45.49%	19,554 $2.89 Million
Q3 2017 Nov 13, 2017	BUY	$114.6 - $136.81 $1.54 Million - $1.84 Million	13,440	13,440 $1.58 Million

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.